senolytic peptide foxo4-dri human study The disordered p53 transactivation domain is the target of FOXO4 and the compound 2% GHK-CU Peptide Serum research bundle Size:Five
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5